Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy